Another GWAS linked SLC9A4 with regulation of IL-33/ST2 (suppression of tumorigenicity 2, part of the IL-1R family) signaling, which has previously been implicated in both immune and inflammatory diseases, including cardiovascular disease [24]. Here, IL1R1 is linked to cardiovascular disorder.